The spread of CTX-M-type extended-spectrum β-lactamases

Clinical Microbiology and Infection

Volumn 14, Issue SUPPL. 1, 2008, Pages 33-41

  Rossolini, G M ^a   D'Andrea, M M ^a   Mugnaioli, C ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

CTX M; Enterobacteriaceae; Epidemiology; Extended spectrum b lactamase; Review

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ASPARTIC ACID; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORINASE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; GLYCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALLOTYPE; AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIA; BACTERIAL CHROMOSOME; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CANADA; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; EUROPE; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; KLUYVERA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOUTH AMERICA;

ENTEROBACTERIACEAE; KLUYVERA;

EID: 37249072281     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01867.x     Document Type: Review

References (38)

1. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med 2005; 352: 380-391.
2. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-686.
3. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
4. Bonnet R. Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
5. Rodriguez MM, Power P, Radice M et al. Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: A possible origin of plasmid-borne CTX-M-1-derived cefotaximases. Antimicrob Agents Chemother 2004; 48: 4895-4897.
6. Olson AB, Silverman M, Boyd DA et al. Identification of a progenitor of the CTX-M-9 group of extended-spectrum β-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob Agents Chemother 2005; 49: 2112-2115.
7. Lartigue MF, Poirel L, Aubert D et al. Invitro analysis of IS Ecp1B -mediated mobilization of naturally occurring β-lactamase gene bla CTX-M of Kluyvera ascorbata. Antimicrob Agents Chemother 2006; 50: 1282-1286.
8. Poirel L, Lartigue MF, Decousser JW et al. IS Ecp1B -mediated transposition of bla CTX-M in Escherichia coli. Antimicrob Agents Chemother 2005; 49: 447-450.
9. Chen Y, Delmas J, Sirot J et al. Atomic resolution structures of CTX-M β-lactamases: Extended spectrum activities from increased mobility and decreased stability. J Mol Biol 2005; 348: 349-362.
10. Ibuka AS, Ishii Y, Galleni M et al. Crystal structure of extended-spectrum β-lactamase Toho-1: Insights into the molecular mechanism for catalytic reaction and substrate specificity expansion. Biochemistry 2003; 42: 10634-10643.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement. Wayne, PA: Clinical Laboratory Standards Institute, 2006.
12. Cartelle M, Del Mar TM, Molina F et al. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 2004; 48: 2308-2313.
13. Bae IK, Lee BH, Hwang HY et al. A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position167 in the omega loop. J Antimicrob Chemother 2006; 58: 315-319.
14. Kimura S, Ishiguro M, Ishii Y et al. Role of a mutation at position167 of CTX-M-19 in ceftazidime hydrolysis. Antimicrob Agents Chemother 2004; 48: 1454-1460.
15. Pournaras S, Ikonomidis A, Kristo I et al. CTX-M enzymes are the most common extended-spectrum β-lactamases among Escherichia coli in a tertiary Greek hospital. J Antimicrob Chemother 2004; 54: 574-575.
16. Yan JJ, Hsueh PR, Lu JJ et al. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 2006; 50: 1861-1864.
17. Edelstein M, Pimkin M, Palagin I et al. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47: 3724-3732.
18. Livermore DM, Hawkey PM. CTX-M: Changing the face of ESBLs in the UK. J Antimicrob Chemother 2005; 56: 451-454.
19. Hernandez JR, Martinez-Martinez L, Canton R et al. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 2005; 49: 2122-2125.
20. Luzzaro F, Mezzatesta M, Mugnaioli C et al. Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: Report of the second Italian nationwide survey. J Clin Microbiol 2006; 44: 1659-1664.
21. Mugnaioli C, Luzzaro F, De Luca F et al. CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 2006; 50: 2700-2706.
22. Eckert C, Gautier V, Saladin-Allard M et al. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48: 1249-1255.
23. Eisner A, Fagan EJ, Feierl G et al. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob Agents Chemother 2006; 50: 785-787.
24. Fang H, Lundberg C, Olsson-Liljequist B et al. Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum β-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J Clin Microbiol 2004; 42: 5917-5920.
25. Brigante G, Luzzaro F, Perilli M et al. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 2005; 25: 157-162.
26. Pitout JD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-59.
27. Ben-Ami R, Schwaber MJ, Navon-Venezia S et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006; 42: 925-934.
28. Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769-4775.
29. Brinas L, Moreno MA, Teshager T et al. Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrob Agents Chemother 2005; 49: 1262-1264.
30. Kojima A, Ishii Y, Ishihara K et al. Extended-spectrum-β-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: Report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrob Agents Chemother 2005; 49: 3533-3537.
31. Carattoli A, Lovari S, Franco A et al. Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 833-835.
32. Elliott E, Brink AJ, Van Greune J et al. Invivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis 2006; 42: e95-e98.
33. Munday CJ, Boyd DA, Brenwald N et al. Molecular and kinetic comparison of the novel extended-spectrum β-lactamases CTX-M-25 and CTX-M-26. Antimicrob Agents Chemother 2004; 48: 4829-4834.
34. Toleman MA, Bennett PM, Walsh TR. IS CR elements: Novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev 2006; 70: 296-316.
35. Oliver A, Coque TM, Alonso D etal. CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother 2005; 49: 1567-1571.
36. Mulvey MR, Bryce E, Boyd D et al. Ambler classA extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 2004; 48: 1204-1214.
37. Quinteros M, Radice M, Gardella N et al. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 2003; 47: 2864-2867.
38. Ryoo NH, Kim EC, Hong SG et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005; 56: 698-702.